vs
AGIOS PHARMACEUTICALS, INC.（AGIO）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是AGIOS PHARMACEUTICALS, INC.的1.6倍（$32.3M vs $20.0M），RBB Bancorp净利率更高（31.5% vs -541.1%，领先572.6%），AGIOS PHARMACEUTICALS, INC.同比增速更快（86.1% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-97.3M），过去两年AGIOS PHARMACEUTICALS, INC.的营收复合增速更高（56.1% vs 7.0%）
Agios Pharmaceuticals是一家美国上市制药企业，创立于2008年，专注于开发针对基因定义疾病的创新疗法，近期核心方向为溶血性贫血治疗药物，总部位于马萨诸塞州剑桥市，2013年7月完成首次公开募股。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
AGIO vs RBB — 直观对比
营收规模更大
RBB
是对方的1.6倍
$20.0M
营收增速更快
AGIO
高出73.5%
12.6%
净利率更高
RBB
高出572.6%
-541.1%
自由现金流更多
RBB
多$139.9M
$-97.3M
两年增速更快
AGIO
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $32.3M |
| 净利润 | $-108.0M | $10.2M |
| 毛利率 | 90.6% | — |
| 营业利润率 | -608.9% | 39.5% |
| 净利率 | -541.1% | 31.5% |
| 营收同比 | 86.1% | 12.6% |
| 净利润同比 | -11.9% | 132.1% |
| 每股收益（稀释后） | $-1.86 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGIORBB
| Q4 25 | $20.0M | $32.3M | ||
| Q3 25 | $12.9M | $32.6M | ||
| Q2 25 | $12.5M | $35.8M | ||
| Q1 25 | $8.7M | $28.5M | ||
| Q4 24 | $10.7M | $28.7M | ||
| Q3 24 | $9.0M | $30.3M | ||
| Q2 24 | $8.6M | $27.5M | ||
| Q1 24 | $8.2M | $28.2M |
净利润AGIORBB
| Q4 25 | $-108.0M | $10.2M | ||
| Q3 25 | $-103.4M | $10.1M | ||
| Q2 25 | $-112.0M | $9.3M | ||
| Q1 25 | $-89.3M | $2.3M | ||
| Q4 24 | $-96.5M | $4.4M | ||
| Q3 24 | $947.9M | $7.0M | ||
| Q2 24 | $-96.1M | $7.2M | ||
| Q1 24 | $-81.5M | $8.0M |
毛利率AGIORBB
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
营业利润率AGIORBB
| Q4 25 | -608.9% | 39.5% | ||
| Q3 25 | -907.4% | 40.7% | ||
| Q2 25 | -1020.1% | 36.1% | ||
| Q1 25 | -1222.0% | 11.2% | ||
| Q4 24 | -1165.3% | 17.6% | ||
| Q3 24 | -1146.9% | 31.6% | ||
| Q2 24 | -1228.3% | 35.6% | ||
| Q1 24 | -1124.3% | 39.9% |
净利率AGIORBB
| Q4 25 | -541.1% | 31.5% | ||
| Q3 25 | -803.1% | 31.2% | ||
| Q2 25 | -899.4% | 26.1% | ||
| Q1 25 | -1023.3% | 8.0% | ||
| Q4 24 | -899.6% | 15.3% | ||
| Q3 24 | 10574.7% | 23.1% | ||
| Q2 24 | -1115.7% | 26.4% | ||
| Q1 24 | -995.8% | 28.4% |
每股收益（稀释后）AGIORBB
| Q4 25 | $-1.86 | $0.59 | ||
| Q3 25 | $-1.78 | $0.59 | ||
| Q2 25 | $-1.93 | $0.52 | ||
| Q1 25 | $-1.55 | $0.13 | ||
| Q4 24 | $-1.44 | $0.26 | ||
| Q3 24 | $16.22 | $0.39 | ||
| Q2 24 | $-1.69 | $0.39 | ||
| Q1 24 | $-1.45 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $1.2B | $523.4M |
| 总资产 | $1.3B | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资AGIORBB
| Q4 25 | $89.1M | $212.3M | ||
| Q3 25 | $92.7M | $234.9M | ||
| Q2 25 | $80.9M | $191.9M | ||
| Q1 25 | $79.0M | $238.8M | ||
| Q4 24 | $76.2M | $257.7M | ||
| Q3 24 | $253.7M | $349.4M | ||
| Q2 24 | $84.5M | $252.8M | ||
| Q1 24 | $118.8M | — |
总债务AGIORBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益AGIORBB
| Q4 25 | $1.2B | $523.4M | ||
| Q3 25 | $1.3B | $514.3M | ||
| Q2 25 | $1.4B | $517.7M | ||
| Q1 25 | $1.5B | $510.3M | ||
| Q4 24 | $1.5B | $507.9M | ||
| Q3 24 | $1.6B | $509.7M | ||
| Q2 24 | $660.5M | $511.3M | ||
| Q1 24 | $743.9M | $514.0M |
总资产AGIORBB
| Q4 25 | $1.3B | $4.2B | ||
| Q3 25 | $1.4B | $4.2B | ||
| Q2 25 | $1.5B | $4.1B | ||
| Q1 25 | $1.6B | $4.0B | ||
| Q4 24 | $1.7B | $4.0B | ||
| Q3 24 | $1.8B | $4.0B | ||
| Q2 24 | $773.1M | $3.9B | ||
| Q1 24 | $849.7M | $3.9B |
负债/权益比AGIORBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.2M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-97.3M | $42.6M |
| 自由现金流率自由现金流/营收 | -487.5% | 131.8% |
| 资本支出强度资本支出/营收 | 5.6% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-377.3M | $73.5M |
8季度趋势，按日历期对齐
经营现金流AGIORBB
| Q4 25 | $-96.2M | $43.4M | ||
| Q3 25 | $-88.2M | $2.1M | ||
| Q2 25 | $-77.1M | $21.7M | ||
| Q1 25 | $-111.5M | $7.8M | ||
| Q4 24 | $-133.2M | $58.5M | ||
| Q3 24 | $-84.2M | $24.5M | ||
| Q2 24 | $-72.6M | $11.7M | ||
| Q1 24 | $-99.9M | $4.8M |
自由现金流AGIORBB
| Q4 25 | $-97.3M | $42.6M | ||
| Q3 25 | $-89.7M | $1.8M | ||
| Q2 25 | $-78.0M | $21.6M | ||
| Q1 25 | $-112.3M | $7.6M | ||
| Q4 24 | $-134.1M | $57.7M | ||
| Q3 24 | $-84.6M | $24.2M | ||
| Q2 24 | $-72.7M | $11.5M | ||
| Q1 24 | $-100.0M | $4.7M |
自由现金流率AGIORBB
| Q4 25 | -487.5% | 131.8% | ||
| Q3 25 | -696.5% | 5.4% | ||
| Q2 25 | -626.2% | 60.2% | ||
| Q1 25 | -1286.4% | 26.7% | ||
| Q4 24 | -1250.1% | 201.0% | ||
| Q3 24 | -944.2% | 80.0% | ||
| Q2 24 | -844.4% | 42.0% | ||
| Q1 24 | -1221.2% | 16.6% |
资本支出强度AGIORBB
| Q4 25 | 5.6% | 2.5% | ||
| Q3 25 | 12.1% | 1.1% | ||
| Q2 25 | 7.0% | 0.3% | ||
| Q1 25 | 8.8% | 0.6% | ||
| Q4 24 | 9.0% | 2.7% | ||
| Q3 24 | 4.7% | 0.8% | ||
| Q2 24 | 1.8% | 0.5% | ||
| Q1 24 | 1.7% | 0.5% |
现金转化率AGIORBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | -0.09× | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
